Skip to main content

Day: August 26, 2024

Massey Ferguson 9S Series Tractor Brings Efficiency and Dependability to Your Farm

MF 9S Series Helps Farmers Who Demand More Achieve a Better Overall Cost of OwnershipDULUTH, Ga., Aug. 26, 2024 (GLOBE NEWSWIRE) — AGCO Corporation (NYSE: AGCO), a global leader in the design, manufacture, and distribution of agricultural machinery and precision ag technology, announces the North American debut of the Massey Ferguson® 9S Series tractor. Designed with the farmer in mind, the MF 9S Series offers better dependability and efficiency to help farmers achieve a lower overall cost of ownership. Massey Ferguson will showcase the MF 9S Series during the 2024 Farm Progress Show in Boone, Iowa, August 27-29. “This machine is an industry-leading planting, baling and tillage solution, designed by and for farmers,” Brad Arnold, Vice President of Massey Ferguson North America, said. Achieve Better OutcomesThe MF 9S Series is...

Continue reading

OROCO ANNOUNCES FILING OF TECHNICAL REPORT AND PEA UPDATE WEBINAR

VANCOUVER, CANADA, Aug. 26, 2024 (GLOBE NEWSWIRE) — Oroco Resource Corp. (“Oroco” or the “Company”) (TSXV: OCO; OTCQB: ORRCF, BF: OR6) is pleased to announce the filing of an independently prepared Preliminary Economic Assessment (“PEA”) technical report (the “Report”) for its Santo Tomas Project in Sinaloa, Mexico.  The Report, dated August 20, 2024 and titled “Santo Tomas Copper Project NI 43-101 Technical Report and Preliminary Economic Assessment”, has been prepared in accordance with National Instrument 43-101 – Standards of Disclosure of Mineral Projects.  Results of the PEA were previously announced in the Company’s news release dated August 20, 2024.  There are no differences in the Report from those results previously reported.  The Report is available on the Company’s website at www.orocoresourcecorp.com and on SEDAR...

Continue reading

100% Renewable Energy for Los Azules

TORONTO, Aug. 26, 2024 (GLOBE NEWSWIRE) — McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) is pleased to announce that its 48%-owned McEwen Copper Inc. has secured an agreement with YPF Luz to power its large Los Azules copper project with 100% renewable energy. This exclusive agreement covers the supply of renewable energy through a high-voltage transmission line, with YPF Luz responsible for its development and financing. YPF Luz and McEwen Copper have signed a Memorandum of Understanding (MOU) that allows the companies to negotiate the exclusive energy supply for the Los Azules project in the San Juan province using renewable energy sources. The agreement also includes connecting the project to the Argentine Interconnection System (SADI) via a high-voltage transmission line, the design, construction, and financing of which will be...

Continue reading

Harvard Apparatus Regenerative Technology Announces $5 Million Financing to Continue Clinical Trial

Holliston, MA, Aug. 26, 2024 (GLOBE NEWSWIRE) — Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN) (“Harvard Apparatus Regenerative Technology” or the “Company”), a clinical-stage biotechnology company developing the technology to regenerate organs inside the body to treat severe diseases, today announced that it has raised approximately $5 million from a new investor in a private placement of its shares. Additional details are provided below. The funds will be used to accelerate the clinical development of HRGN’s lead product candidate, the HRGN Esophageal Implant, or BEI. The FDA has approved a ten-patient phase one and phase two clinical trial to study the repair of damage to the esophagus in adults caused by cancer or injury. The FDA has indicated a willingness to consider expanding this clinical trial to include...

Continue reading

Solvay: acquisition of own shares

Brussels, August 26, 2024, 6:00pm CEST  –  Regulated information In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code of Companies and Associations, Solvay SA hereby discloses certain information in relation to its Share Buyback Program, announced on August 1, 2024. Solvay has repurchased 122,323 Solvay shares in the period from August 19, 2024 up to and including August 23, 2024, as follows:Date of repurchase Number of shares Average price paid Max price paid Min price paid Total Market19-08-2024 972 31.0040 31.1700 30.8100 30,135.89 AQEU19-08-2024 3,873 30.8978 31.1800 30.7700 119,667.18 CEUX19-08-2024 1,091 30.9918 31.2000 30.7800 33,812.05 TQEX19-08-2024 24,064 30.8925 31.3000 30.6900 743,397.12 XBRU20-08-2024 2,324 30.6540 30.8600 30.5200 71,239.90 AQEU20-08-2024 17,641 30.7439 30.9900 30.5900 542,353.14 CEUX20-08-2024 4,381 30.7101 31.0000 30.5200 134,540.95 TQEX20-08-2024 24,654 30.6424 31.1600 30.4900 755,457.73 XBRU21-08-2024 590 30.7750 30.9800 30.6600 18,157.25 AQEU21-08-2024 8,840 30.8669 30.9800 30.6500 272,863.40 CEUX21-08-2024 2,064 30.8127 30.9700 30.6600 63,597.41 TQEX21-08-2024 14,506 30.8179 30.9800 30.5900 447,044.46 XBRU22-08-2024 317 31.0104 31.0800 30.9500 9,830.30 AQEU22-08-2024 3,215 31.0052 31.1100 30.9500 99,681.72 CEUX22-08-2024 1,233 31.0794 31.1300 30.9500 38,320.90 TQEX22-08-2024 6,121 31.0007 31.2100 30.8100 189,755.28 XBRU23-08-2024 425 31.2772 31.2900 31.2600 13,292.81 AQEU23-08-2024 1,123 31.2802 31.3000 31.2500 35,127.66 CEUX23-08-2024 364 31.2744 31.2900 31.2500 11,383.88 TQEX23-08-2024 4,525 31.2819 31.4000 31.2300 141,550.60 XBRUAs...

Continue reading

Rexel: Disclosure of trading in own shares from August 19 to August 23, 2024

RELEASE                   DISCLOSURE OF TRADING IN OWN SHARES FROM AUGUST 19 TO AUGUST 23, 2024 In accordance with the authorization granted by the Shareholders’ Meeting in order to trade in own shares and pursuant to applicable law on share repurchases, Rexel declares the following purchases of its own shares from August 19 to August 23, 2024:Name of the issuer Identity code of the Issuer Day of the transaction Identity code of the financialinstrument Total daily volume (innumber of shares) Daily weighted averagepurchase price of the shares Market (MIC Code)REXEL 969500N6AVPA51648T62 19/08/2024 FR0010451203 2 500 22,558 AQEUREXEL 969500N6AVPA51648T62 19/08/2024 FR0010451203 13 000 22,55654 CCXEREXEL 969500N6AVPA51648T62 19/08/2024 FR0010451203 2 000 22,475 TQEXREXEL 969500N6AVPA51648T62 19/08/2024 FR0010451203 23...

Continue reading

Genmab to Present at Morgan Stanley 22nd Annual Global Healthcare Conference

Media Release COPENHAGEN, Denmark; August 26, 2024 Genmab A/S (Nasdaq: GMAB) announced today that its Chief Executive Officer Jan van de Winkel, Ph.D. and Chief Financial Officer Anthony Pagano will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference at 1:05 PM EDT / 7:05 PM CEST on September 4, 2024.  A webcast of the event, which will include brief opening remarks followed by a question-and-answer session, will be available on Genmab’s website at https://ir.genmab.com/events-presentations. About Genmab Genmab is an international biotechnology company with a core purpose of guiding its unstoppable team to strive toward improving the lives of patients with innovative and differentiated antibody therapeutics. For 25 years, its passionate, innovative and collaborative team has invented next-generation...

Continue reading

BioNexus Gene Lab Corp. Completes Strategic RM 1 Million Investment in Ascension Innovation Sdn Bhd

KUALA LUMPUR, Malaysia, Aug. 27, 2024 (GLOBE NEWSWIRE) — BioNexus Gene Lab Corp. (NASDAQ: BGLC), an emerging leader in genomic diagnostics and health technology, today announced the successful closing of its RM 1 million (Approx. USD228k) investment in Ascension Innovation Sdn Bhd (AISB), a pioneering Malaysian healthcare technology firm. This strategic investment, executed through BGLC’s wholly-owned subsidiary, MRNA Scientific Sdn Bhd, solidifies BGLC’s commitment to advancing AI-driven healthcare solutions. AISB specializes in innovative healthcare technologies, particularly through its flagship platform, aiCMS, which integrates advanced predictive analytics and AI tools to enhance clinical management and patient care. The investment provides BGLC with a significant equity stake in AISB, enabling deeper collaboration between...

Continue reading

STEALTHGAS INC. Announces the Date for the Release of the Second Quarter and Six Months 2024 Financial and Operating Results, Conference Call and Webcast

ATHENS, Greece, Aug. 26, 2024 (GLOBE NEWSWIRE) — STEALTHGAS INC. (NASDAQ: GASS) (the “Company”), a ship-owning company serving the liquefied petroleum gas (LPG) sector of the international shipping industry, announced today that it will release its second quarter operating and financial results for the period ended June 30, 2024 before the market opens in New York on September 5, 2024. On September 5, 2024 at 11:00 am ET, the company’s management will host a conference call to discuss the results and the company’s operations and outlook. Conference Call details: Conference call participants should pre-register using the below link to receive the dial-in numbers and a personal PIN, which are required to access the conference call. Online Registration: https://register.vevent.com/register/BI25c34f509b4240f9bdb0dfde53c8fd42 Slides...

Continue reading

NNIT A/S: SOLID ORGANIC GROWTH OF 11%, PROFITABILITY CONTINUED TO IMPROVE, AND IMPORTANT STRATEGIC MILESTONES REACHED

Q2 2024 key highlightsFinancial performance continued to improve during the second quarter with organic growth at 11.0% meaning NNIT is capturing market share, specifically in Denmark and Europe. Growth was seen across all regions, with the exception of Region US, which continued to be negatively impacted by the temporary decline in the data migration business, despite gradual improvements. Group operating profit margin excluding special items ended at 6.7%, which is an 0.8%-point increase compared with last year. The improvement in profitability was partly driven by leveraging the cost base due to the top line increase, and partly due to the tight cost control and efforts made in Region Asia during the first quarter. Important steps on our transformative journey continued with the new global ERP and HR systems going live, on-track completion...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.